Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Business
•
November 16, 2026
•
6 views
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


